Xenbase Image ID: 123182

Figure 5. The requirement for Xic1 in cardiomyocyte differentiation is distinct from its ability to arrest the cell cycle. Stage-29/30 embryos either uninjected (A and H) or injected with CTRMo (B and I), Xic1Mo (C, J, and P), or Xic1Mo plus FL-Xic1 (30 pg) (D, K, and Q), NT-Xic1 (15 pg) (E and L), CT-Xic1 (30 pg) (F and M), Xic1(35–96) (30 pg) (G and N), Xic1CK- (R), or CTRMo plus Xic1CK- (S) detecting either Nkx2.10 (A–G) or TIc (H–S). (T) Percentage of stage-29/30 embryos with heart sizes 1–3 (cf. Figure 4) following injection with Mo and mRNA combinations as described. n = 26 – 53 embryos/treatment group. Image published in: Movassagh M and Philpott A (2008) Published on behalf of the European Society of Cardiology. This image is reproduced with permission of the journal and the copyright holder. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license Gene Synonyms Species Stage(s) Tissue nkx2-6.L nkx2.6, tix, Xnkx2-10 X. laevis Throughout NF stage 29 and 30 heart cdknx.L p27Xic-1, p27XIC1, p28, Xic-1, Xic1 X. laevis Throughout NF stage 29 and 30 heart Image source: Published Larger Image Printer Friendly View

Return to previous page